Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Electrospun F18 Bioactive Glass/PCL-Poly (epsilon-caprolactone)-Membrane for Guided Tissue Regeneration

Full text
Author(s):
Pitaluga, Lucas Hidalgo [1] ; Souza, Marina Trevelin [1] ; Zanotto, Edgar Dutra [1] ; Romero, Martin Eduardo Santocildes [2] ; Hatton, Paul V. [2]
Total Authors: 5
Affiliation:
[1] Univ Fed Sao Carlos, Dept Mat Engn, CERTEV Ctr Res Technol & Educ Vitreous Mat, BR-13565905 Sao Carlos, SP - Brazil
[2] Univ Sheffield, Sch Clin Dent, 19 Claremont Crescent, Sheffield S10 2TA, S Yorkshire - England
Total Affiliations: 2
Document type: Journal article
Source: MATERIALS; v. 11, n. 3 MAR 2018.
Web of Science Citations: 6
Abstract

Barrier membranes that are used for guided tissue regeneration (GTR) therapy usually lack bioactivity and the capability to promote new bone tissue formation. However, the incorporation of an osteogenic agent into polymeric membranes seems to be the most assertive strategy to enhance their regenerative potential. Here, the manufacturing of composite electrospun membranes made of poly (epsilon-caprolactone) (PCL) and particles of a novel bioactive glass composition (F18) is described. The membranes were mechanically and biologically tested with tensile strength tests and tissue culture with MG-63 osteoblast-like cell line, respectively. The PCL-F18 composite membranes demonstrated no increased cytotoxicity and an enhanced osteogenic potential when compared to pure PCL membranes. Moreover, the addition of the bioactive phase increased the membrane tensile strength. These preliminary results suggested that these new membranes can be a strong candidate for small bone injuries treatment by GTR technique. (AU)

FAPESP's process: 13/07793-6 - CEPIV - Center for Teaching, Research and Innovation in Glass
Grantee:Edgar Dutra Zanotto
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC